Department of Physical Medicine and Rehabilitation UT Southwestern Medical Center Dallas TX USA.
Department of Biostatistics University of Texas Health Science Center at Houston School of Public Health Houston TX USA.
J Am Heart Assoc. 2024 Mar 5;13(5):e030537. doi: 10.1161/JAHA.123.030537. Epub 2024 Feb 23.
To inform clinical practice, we sought to identify racial and ethnic differences in the medical management of common poststroke complications.
A cohort of acutely hospitalized, first-time non-Hispanic White (NHW), non-Hispanic Black, and Hispanic patients with stroke was identified from electronic medical records of 51 large health care organizations (January 1, 2003 to December 5, 2022). Matched propensity scores were used to account for baseline differences. Primary outcomes included receipt of medication(s) associated with the management of the following poststroke complications: arousal/fatigue, spasticity, mood, sleep, neurogenic bladder, neurogenic bowel, and seizure. Differences were measured at 14, 90, and 365 days. Subgroup analyses included differences restricted to patients with ischemic stroke, younger age (<65 years), and stratified by decade (2003-2012 and 2013-2022). Before matching, the final cohort consisted of 348 286 patients with first-time stroke. Matching resulted in 63 722 non-Hispanic Black-NHW pairs and 24 009 Hispanic-NHW pairs. Non-Hispanic Black (versus NHW) patients were significantly less likely to be treated for all poststroke complications, with differences largest for arousal/fatigue (relative risk (RR), 0.58 [95% CI, 0.54-0.62]), spasticity (RR, 0.64 [95% CI, 0.0.62-0.67]), and mood disorders (RR, 0.72 [95% CI, 0.70-0.74]) at 14 days. Hispanic-NHW differences were similar, albeit with smaller magnitudes, with the largest differences present for spasticity (RR, 0.67 [95% CI, 0.63-0.72]), arousal/fatigue (RR, 0.77 [95% CI, 0.70-0.85]), and mood disorders (RR, 0.79 [95% CI, 0.77-0.82]). Subgroup analyses revealed similar patterns for ischemic stroke and patients aged <65 years. Disparities for the current decade remained significant but with smaller magnitudes compared with the prior decade.
There are significant racial and ethnic disparities in the treatment of poststroke complications. The differences were greatest at 14 days, outlining the importance of early identification and management.
为了指导临床实践,我们旨在确定非裔美国人和西班牙裔患者与非裔美国人和非西班牙裔白人(NHW)患者在常见卒中后并发症的医疗管理方面的种族差异。
从 51 家大型医疗机构的电子病历中确定了急性住院的首次非西班牙裔白人(NHW)、非西班牙裔黑人和西班牙裔卒中患者队列(2003 年 1 月 1 日至 2022 年 12 月 5 日)。使用匹配的倾向评分来解释基线差异。主要结局包括接受与以下卒中后并发症管理相关的药物治疗:觉醒/疲劳、痉挛、情绪、睡眠、神经源性膀胱、神经源性肠和癫痫。差异在 14、90 和 365 天进行测量。亚组分析包括仅限于缺血性卒中患者、年龄较小(<65 岁)和按十年分层(2003-2012 年和 2013-2022 年)的差异。在匹配之前,最终队列包括 348286 名首次卒中患者。匹配后产生 63722 对非西班牙裔黑人-NHW 配对和 24009 对西班牙裔-NHW 配对。与 NHW 患者相比,非西班牙裔黑人患者接受所有卒中后并发症治疗的可能性明显较低,差异最大的是觉醒/疲劳(相对风险(RR),0.58[95%CI,0.54-0.62])、痉挛(RR,0.64[95%CI,0.62-0.67])和情绪障碍(RR,0.72[95%CI,0.70-0.74])在 14 天。西班牙裔-NHW 差异相似,尽管幅度较小,最大差异存在于痉挛(RR,0.67[95%CI,0.63-0.72])、觉醒/疲劳(RR,0.77[95%CI,0.70-0.85])和情绪障碍(RR,0.79[95%CI,0.77-0.82])。亚组分析显示,缺血性卒中和年龄<65 岁的患者存在类似的模式。当前十年的差异仍然显著,但与前十年相比幅度较小。
在卒中后并发症的治疗中存在显著的种族和民族差异。差异在 14 天最大,强调了早期识别和管理的重要性。